Fighting alterations in brain health
Millions of people in the United States are affected by neurodegenerative diseases like Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. As our population ages, these diseases become more common and place an increased burden on medical systems and caregivers.
The ASU-Banner Neurodegenerative Disease Research Center advances the discovery of disease mechanisms, risk factors, biomarkers, and drugs for the understanding, detection, tracking, treatment and prevention of neurodegenerative diseases. The center is a partnership between Banner Health and Arizona State University.
Jeffrey Kordower employs gene therapy, neural transplantation and the discovery of molecular changes to his research of Alzheimer’s, Parkinson’s and Huntington’s diseases. He has led numerous gene and cell therapy preclinical studies that have gone on to clinical trials. Kordower’s findings have included the first demonstration that dopaminergic grafts can survive, innervate and form synapses in patients with Parkinson’s disease, and he and his collaborators were the first to show that long-term grafts in such patients can form Lewy bodies.
Meet our center’s experts
Our center is supported by a knowledgeable team of researchers, staff and visionary leaders who are at the leading edge of their fields.
For questions about collaborations and center administration, please contact:
Support the ASU-Banner Neurodegenerative Disease Research Center
Advancing the scientific study, treatment and prevention of Alzheimer’s, Parkinson’s and other neurodegenerative diseases through an ASU-Banner Health research alliance.